'I'm Not Proud Of Myself': Jim Cramer Says He Bought 'Worst Of The Three' GE Stocks

Zinger Key Points
  • Jim Cramer says Merck & Co., is a buy.
  • Fortinet reported a "very good" quarter, says Cramer.

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Merck & Co., Inc. MRK. “I have tremendous, tremendous faith in what Robert Davis [CEO of Merck] is doing,” he added.

When asked about Teladoc Health, Inc TDOC, he said, “What's going on there, right now we've got this Cathie Wood, she sells the stock almost every day. She bought it much higher, it's really painful to watch.”

Fortinet, Inc. FTNT reported a “very good” quarter, he said. “I remain committed to Nikesh Arora [CEO of Palo Alto Networks] and Palo Alto Networks PANW, which I think is doing the best of all of them.”

Enova International, Inc. ENVA is a “little dicey,” Cramer said, “A little dicey because it's untraditional lending. I am just a traditionalist. I say go with the stock that collapsed over the last week, go with Wells Fargo & Co WFC.”

“This is enterprise software, and, you know, there is more money being lost in enterprise software in 2024 than in any other sector, so I can't play, I'm sorry,” Cramer said when asked about Bentley Systems, Incorporated BSY.

GE HealthCare Technologies Inc. GEHC reported a “decent” quarter and has been hurt by China, he said. “I bought the worst of the three, and I'm not proud of myself.”

Price Action:

  • Teladoc Health shares gained 0.7% to settle at $7.21 on Thursday.
  • Fortinet shares fell 1.8% to close at $68.68.
  • Merck shares gained 1.3% to close at $113.92.
  • Enova International shares rose 1.7% to close at $76.85.
  • GE Healthcare shares gained 3.8% to settle at $82.32 on Thursday.
  • Bentley Systems shares rose 5.1% to close at $49.25 on Thursday.

Read Next:

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!